Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 06, 2020 at 04:12 pm
Share
GeneFerm Biotechnology Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 82.946 million compared to TWD 79.555 million a year ago. Operating income was TWD 3.406 million compared to operating loss of TWD 9.008 million a year ago. Net income was TWD 2,000 compared to net loss of TWD 8.735 million a year ago. Basic eps was TWD 0 compared to basic loss per share of TWD 0.31 a year ago. For the half year, sales was TWD 171.675 million compared to TWD 152.142 million a year ago. Operating loss was TWD 1.647 million compared to TWD 13.284 million a year ago. Net loss was TWD 5.693 million compared to TWD 13.539 million a year ago. Basic loss per share was TWD 0.2 compared to TWD 0.49 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.